Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+10,282,919
Put/Call ratio
109%
SEC-reported price per share
$2.36
Number of holders
84
Value change
+$24,478,369
Number of buys
50
Open additional details 1 more signal available
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,227,200

Security key

00509G209

Report period

Q1 2026

Institutions

84

Top holders

10

Ownership snapshot

Top reported holders of ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
13 Mar 2026
13D/G 13F Lead comparable stake: 30% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 30%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 30%
Sands Capital Alternatives, LLC 5.6%
James B. Murray Jr. 5%
FRANKLIN RESOURCES INC 3.8%
FMR LLC 2.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
30%
$55,075,356
21,101,669 shares
+$15,883,432 13 Mar 2026
Sands Capital Alternatives, LLC
13F 13D/G
Company
5.6%
from 13D/G
$7,210,028
3,417,075 shares
31 Dec 2025
James B. Murray Jr.
13D/G
5%
$9,425,650
3,611,360 shares
$0 04 Apr 2025
FRANKLIN RESOURCES INC
13F 13D/G
Company
3.8%
from 13D/G
$4,863,753
2,305,096 shares
31 Dec 2025
FMR LLC
13F
Company
13F
2.8%
$4,278,019
2,027,497 shares
31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
2.3%
$3,489,459
1,653,772 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
84
Shares
46,001,051
Rows available
84
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
84
Q1 2026 holders
84
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .